605 related articles for article (PubMed ID: 27609333)
1. Urine metabolome profiling of immune-mediated inflammatory diseases.
Alonso A; Julià A; Vinaixa M; Domènech E; Fernández-Nebro A; Cañete JD; Ferrándiz C; Tornero J; Gisbert JP; Nos P; Casbas AG; Puig L; González-Álvaro I; Pinto-Tasende JA; Blanco R; Rodríguez MA; Beltran A; Correig X; Marsal S;
BMC Med; 2016 Sep; 14(1):133. PubMed ID: 27609333
[TBL] [Abstract][Full Text] [Related]
2. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases.
Dawiskiba T; Deja S; Mulak A; Ząbek A; Jawień E; Pawełka D; Banasik M; Mastalerz-Migas A; Balcerzak W; Kaliszewski K; Skóra J; Barć P; Korta K; Pormańczuk K; Szyber P; Litarski A; Młynarz P
World J Gastroenterol; 2014 Jan; 20(1):163-74. PubMed ID: 24415869
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
Burisch J; Jess T; Egeberg A
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
[TBL] [Abstract][Full Text] [Related]
4. Sympathetic Nerve Hyperactivity in the Spleen: Causal for Nonpathogenic-Driven Chronic Immune-Mediated Inflammatory Diseases (IMIDs)?
Bellinger DL; Lorton D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652832
[TBL] [Abstract][Full Text] [Related]
5. Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children.
Martin FP; Su MM; Xie GX; Guiraud SP; Kussmann M; Godin JP; Jia W; Nydegger A
World J Gastroenterol; 2017 May; 23(20):3643-3654. PubMed ID: 28611517
[TBL] [Abstract][Full Text] [Related]
6. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.
Aletaha D; Epstein AJ; Skup M; Zueger P; Garg V; Panaccione R
Adv Ther; 2019 Jul; 36(7):1672-1683. PubMed ID: 31102202
[TBL] [Abstract][Full Text] [Related]
7. Urinary metabolomic profiling of a cohort of Colombian patients with systemic lupus erythematosus.
Rojo-Sánchez A; Carmona-Martes A; Díaz-Olmos Y; Santamaría-Torres M; Cala MP; Orozco-Acosta E; Aroca-Martínez G; Pacheco-Londoño L; Navarro-Quiroz E; Pacheco-Lugo LA
Sci Rep; 2024 Apr; 14(1):9555. PubMed ID: 38664528
[TBL] [Abstract][Full Text] [Related]
8. [Metabolomics for Biomarker Discovery in Systemic Lupus Erythematosus].
Saegusa J; Kawano S; Morinobu A
Rinsho Byori; 2015 Apr; 63(4):498-505. PubMed ID: 26536784
[TBL] [Abstract][Full Text] [Related]
9. Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease.
Bjerrum JT; Steenholdt C; Ainsworth M; Nielsen OH; Reed MA; Atkins K; Günther UL; Hao F; Wang Y
BMC Med; 2017 Oct; 15(1):184. PubMed ID: 29032767
[TBL] [Abstract][Full Text] [Related]
10. Untargeted Metabolomics and Inflammatory Markers Profiling in Children With Crohn's Disease and Ulcerative Colitis-A Preliminary Study.
Daniluk U; Daniluk J; Kucharski R; Kowalczyk T; Pietrowska K; Samczuk P; Filimoniuk A; Kretowski A; Lebensztejn D; Ciborowski M
Inflamm Bowel Dis; 2019 Jun; 25(7):1120-1128. PubMed ID: 30772902
[TBL] [Abstract][Full Text] [Related]
11. Urinary NMR metabolomic profiles discriminate inflammatory bowel disease from healthy.
Stephens NS; Siffledeen J; Su X; Murdoch TB; Fedorak RN; Slupsky CM
J Crohns Colitis; 2013 Mar; 7(2):e42-8. PubMed ID: 22626506
[TBL] [Abstract][Full Text] [Related]
12. Propensity-Matched Analysis of the Risk of Age-Related Macular Degeneration with Systemic Immune-Mediated Inflammatory Disease.
Shukla P; Russell MW; Muste JC; Shaia JK; Kumar M; Nowacki AS; Hajj-Ali RA; Singh RP; Talcott KE
Ophthalmol Retina; 2024 Feb; ():. PubMed ID: 38320691
[TBL] [Abstract][Full Text] [Related]
13. Urinary metabolomic study of systemic lupus erythematosus based on gas chromatography/mass spectrometry.
Yan B; Huang J; Dong F; Yang L; Huang C; Gao M; Shi A; Zha W; Shi L; Hu X
Biomed Chromatogr; 2016 Nov; 30(11):1877-1881. PubMed ID: 27061577
[TBL] [Abstract][Full Text] [Related]
14. Large-scale plasma-metabolome analysis identifies potential biomarkers of psoriasis and its clinical subtypes.
Kishikawa T; Arase N; Tsuji S; Maeda Y; Nii T; Hirata J; Suzuki K; Yamamoto K; Masuda T; Ogawa K; Ohshima S; Inohara H; Kumanogoh A; Fujimoto M; Okada Y
J Dermatol Sci; 2021 May; 102(2):78-84. PubMed ID: 33836926
[TBL] [Abstract][Full Text] [Related]
15. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
Lindahl A; Forshed J; Nordström A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
[TBL] [Abstract][Full Text] [Related]
16. Combining mechanism-based prediction with patient-based profiling for psoriasis metabolomics biomarker discovery.
Wang Q; McCormick TS; Ward NL; Cooper KD; Conic R; Xu R
AMIA Annu Symp Proc; 2017; 2017():1734-1743. PubMed ID: 29854244
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease.
Rizzello F; Olivieri I; Armuzzi A; Ayala F; Bettoli V; Bianchi L; Cimino L; Costanzo A; Cristaudo A; D'Angelo S; Daperno M; Fostini AC; Galeazzi M; Gilio M; Gionchetti P; Gisondi P; Lubrano E; Marchesoni A; Offidani A; Orlando A; Pugliese D; Salvarani C; Scarpa R; Vecchi M; Girolomoni G
Adv Ther; 2018 Apr; 35(4):545-562. PubMed ID: 29516409
[TBL] [Abstract][Full Text] [Related]
18. Characterization of inflammatory bowel disease with urinary metabolic profiling.
Williams HR; Cox IJ; Walker DG; North BV; Patel VM; Marshall SE; Jewell DP; Ghosh S; Thomas HJ; Teare JP; Jakobovits S; Zeki S; Welsh KI; Taylor-Robinson SD; Orchard TR
Am J Gastroenterol; 2009 Jun; 104(6):1435-44. PubMed ID: 19491857
[TBL] [Abstract][Full Text] [Related]
19. Identifying serum metabolite biomarkers for autoimmune diseases: a two-sample mendelian randomization and meta-analysis.
Wang W; Huang M; Ge W; Feng J; Zhang X; Li C; Wang L
Front Immunol; 2024; 15():1300457. PubMed ID: 38686387
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
